Back to search

Article

Intermittent Levosimendan Administration for Advanced Heart Failure Treatment in Adults with Congenital Heart Disease

2026-02-12

Abstract excerpt

<h4>Background: </h4> Heart failure (HF) is a major cause of morbidity in adults with congenital heart disease (ACHD), who may also have limited access to transplant. Intermittent levosimendan has shown benefit in advanced HF due to acquired heart disease, but currently there are no data in ACHD. <h4>Methods:</h4> We conducted a retrospective analysis of ACHD patients aged &gt;18 years with advanced HF who receive...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e9126166-fde7-5e8c-93a7-4d23f25986db
DOI
10.20944/preprints202602.0999.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Intermittent Levosimendan Administration for Advanced Heart Failure Treatment in Adults with Congenital Heart DiseaseDOI 10.20944/preprints202602.0999.v1
Select a neighboring publication to make it the new centre.